MiMedx Group, Inc.MDXGNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank43
3Y CAGR+19.9%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
+19.9%/yr
vs -21.1%/yr prior
Acceleration
+41.1pp
Accelerating
Percentile
P43
Within normal range
vs 3Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202523.02%
20240.04%
2023-2.06%
202213.35%
2021-18.98%
2020-9.15%
2019-10.34%
201834.49%
201727.39%
201629.19%